Status:
UNKNOWN
Use of PCR-Sars-CoV-2 in Children
Lead Sponsor:
Centre Hospitalier Intercommunal Creteil
Collaborating Sponsors:
Association Clinique Thérapeutique Infantile du val de Marne
Groupe de Pathologies Infectieuses Pédiatriques (GPIP)
Conditions:
Covid-19
Eligibility:
All Genders
Up to 14 years
Brief Summary
The VIGIL study was set up at the beginning of the pandemic, in the spring of 2020, at a time when diagnostic testing for SARS-CoV-2 had to be performed according to specific clinical criteria (even i...
Eligibility Criteria
Inclusion
- Children under 15 years of age
- Prescription of a PCR-Sars-CoV-2
- VIGIL information note given to parents
Exclusion
- Refusal to participate by the patient, family member or legal representative (depending on the situation)
Key Trial Info
Start Date :
June 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2024
Estimated Enrollment :
12000 Patients enrolled
Trial Details
Trial ID
NCT04412317
Start Date
June 3 2020
End Date
May 30 2024
Last Update
February 8 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
ACTIV network
Créteil, France
2
PARI network
Créteil, France